DEVELOPMENT OF NOVEL METHOD FOR ESTIMATION OF METFOMIN HCL, GLIMEPIRIDE AND VOGLIBOSE IN MULTI INGREDIENT DOSAGE FORM BY DERIVATIVE SPECTROSCOPY
Ashwini S. Deshpande*, Nilesh Ahire, Shashikant B. Bagade, and Shirish S. Deshpande
ABSTRACT
In the present study derivative spectroscopy has been developed for the
estimation of anti diabetic drugs, Metformin HCl, Glimepiride and
Voglibose in multi ingredient tablet formulation. In this study a second
order derivative spectroscopy method was used for estimation of anti
diabetic drugs using zero- crossing method. Method І was based on
simultaneous equation method for estimation of GLM and VOG; the
absorbances were measured at 246nm, 234nm respectively, being the
zero absorbance points for metformin HCl. Method ІІ was based on
calibration curve method for estimation of Metformin hydrochloride
absorbance measured at 256nm. For both the methods second order
derivative spectra was generated between 400-200 nm. There is no
any method reported for the estimation of Metformin hydrochloride, Glimepiride and
Voglibose in multi ingredient tablet dosage form. Hence a simple, sensitive, reliable and
rapid spectroscopic method has been developed for the determination of mentioned drugs in
multi ingredient tablet dosage form. All these drugs obey Beer’s law in the concentration
range between 20-100μg/ml, 20-80μg/ml, and 5-60μg/ml respectively, when converted to
second order derivative. The method was validated as per the ICH criteria for method
validation in terms of accuracy, precision, linearity, specificity, and robustness. This method
could be useful for routing quality control analysis of mentioned drugs and their dosage
forms.
Keywords: Metformin hydrochloride, Glimepiride and Voglibose, Derivative spectroscopy.
[Download Article]
[Download Certifiate]